Investigating the response to intravenous iron in restless legs syndrome: An observational study
Sleep Medicine, 06/29/2012
Hornyak M et al. – Ferric carboxymaltose (FCM) led to a considerable improvement in restless legs syndrome (RLS) in the responder group within about one week. These findings are clinically relevant, especially for patients with severe RLS symptoms and iron deficiency, since a change or uptitration of RLS–specific medication can be avoided or postponed in these patients due to the rapid response to IV FCM treatment.



